Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer
The purpose of this study is to clarify efficacy and toxicity of daily low-dose Nedaplatin
(CDGP) and continuous infusion of 5-FU combined with radiation in patients with esophageal
squamous cell carcinoma.
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
Daiichi Sankyo Co., Ltd.
The purpose of this study is to examine the correlation between UGT1A1 genotypes and the
safety of CPT-11 plus platinum analogues (cisplatin, carboplatin and nedaplatin) regimens
for patients with lung cancer, cervical cancer, ovarian cancer and gastric cancer.
Improve the Treatment of Thoracic Esophageal Cancer
Sun Yat-sen University
The purpose of this study is
1. To compare the effects of the two types of thoracic esophageal cancer lymphadenectomy
on the staging and prognosis of resectable esophageal cancer, which defined by the
International Association of esophageal disease(ISDE) - standard mediastinal
lymphadenectomy,total mediastinal lymphadenectomy and three field lymphadenectomy,and
to find out reasonable range of lymphadenectomy.
2. To compare the effects of Chemotherapy Group (Docetaxel + Nedaplatin) with Control
Group on the prognosis of resectable thoracic esophageal cancer,and to explore the
indications of adjuvant chemotherapy.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.